Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Chemical Industry News Fineotex Chemical reports strong Q1 FY2025 financials and strategic developments Fineotex Chemical Limited, a leading name in India’s specialty chemicals sector, has announced robust financial results for the… byPallavi MadhirajuAugust 10, 2024